newsfilter
← Latest News
Business Wire·

Cybin Acquires DMT Clinical Study from Entheon Biomedical

-- Acquisition of largest Phase 1 DMT study conducted to date is expected to accelerate CYB004 program timeline by nine months -- -- Phase 1 study evaluating pharmacokinetics/pharmacodynamics of DMT currently underway and will inform clinical path fo